Latest News

Mark Egerton, CEO of Quotient Sciences has been featured in and article in Global Business Reports: A Shifting Landscape The outsourcing model is here to stayIn addition to speed, clients also want ease. Rather than working with several ser...

Mark Egerton, CEO, Quotient Sciences: Interview with Global Business ReportQ: How was 2021 for Quotient Sciences, particularly within the US?A: In February 2021, Quotient Sciences expanded its portfolio of services to include drug substance...

Featured Interview with Mark Egerton, CEO of Quotient Sciences with Global Business ReportsHow was 2021 for Quotient Sciences, particularly within the US?In February 2021, Quotient Sciences expanded its portfolio of services to include drug...

John McDermott, Quotient Sciences' Executive Drug Development Consultant, discusses Integrated Development Strategies Overcome Solubility Challenges, in Drug Development & Delivery's Special Feature in Drug Develo...

In this roundtable with Pharma's Almanac, Mark Egerton, CEO of Quotient Sciences, answers the Question 'What’s the key to being a leader in the industry?Featured Roundtable Interview with Mark Egerton, CEO of Quotient Sciences wit...